BACKGROUND: Several epidemiological cross-sectional studies have found positive associations between serum concentrations of lipids and perfluorooctanoic acid (PFOA, or C8). A longitudinal study should be less susceptible to biases from uncontrolled confounding or reverse causality. METHODS: We investigated the association between within-individual changes in serum PFOA and perfluorooctanesulfonic acid (PFOS) and changes in serum lipid levels (low-density lipoprotein [LDL] cholesterol, high-density lipoprotein cholesterol, total cholesterol, and triglycerides) over a 4.4-year period. The study population consisted of 560 adults living in parts of Ohio and West Virginia where public drinking water had been contaminated with PFOA. They had participated in a cross-sectional study in 2005-2006, and were followed up in 2010, by which time exposure to PFOA had been substantially reduced. RESULTS: Overall serum concentrations of PFOA and PFOS fell by half from initial geometric means of 74.8 and 18.5 ng/mL, respectively, with little corresponding change in LDL cholesterol (mean increase 1.8%, standard deviation 26.6%). However, there was a tendency for people with greater declines in serum PFOA or PFOS to have greater LDL decrease. For a person whose serum PFOA fell by half, the predicted fall in LDL cholesterol was 3.6% (95% confidence interval = 1.5-5.7%). The association with a decline in PFOS was even stronger, with a 5% decrease in LDL (2.5-7.4%). CONCLUSIONS: Our findings from this longitudinal study support previous evidence from cross-sectional studies of positive associations between PFOA and PFOS in serum and LDL cholesterol.
BACKGROUND: Several epidemiological cross-sectional studies have found positive associations between serum concentrations of lipids and perfluorooctanoic acid (PFOA, or C8). A longitudinal study should be less susceptible to biases from uncontrolled confounding or reverse causality. METHODS: We investigated the association between within-individual changes in serum PFOA and perfluorooctanesulfonic acid (PFOS) and changes in serum lipid levels (low-density lipoprotein [LDL] cholesterol, high-density lipoprotein cholesterol, total cholesterol, and triglycerides) over a 4.4-year period. The study population consisted of 560 adults living in parts of Ohio and West Virginia where public drinking water had been contaminated with PFOA. They had participated in a cross-sectional study in 2005-2006, and were followed up in 2010, by which time exposure to PFOA had been substantially reduced. RESULTS: Overall serum concentrations of PFOA and PFOS fell by half from initial geometric means of 74.8 and 18.5 ng/mL, respectively, with little corresponding change in LDL cholesterol (mean increase 1.8%, standard deviation 26.6%). However, there was a tendency for people with greater declines in serum PFOA or PFOS to have greater LDL decrease. For a person whose serum PFOA fell by half, the predicted fall in LDL cholesterol was 3.6% (95% confidence interval = 1.5-5.7%). The association with a decline in PFOS was even stronger, with a 5% decrease in LDL (2.5-7.4%). CONCLUSIONS: Our findings from this longitudinal study support previous evidence from cross-sectional studies of positive associations between PFOA and PFOS in serum and LDL cholesterol.
Authors: Scott M Bartell; Antonia M Calafat; Christopher Lyu; Kayoko Kato; P Barry Ryan; Kyle Steenland Journal: Environ Health Perspect Date: 2010-02 Impact factor: 9.031
Authors: Jennifer M Keller; Antonia M Calafat; Kayoko Kato; Mark E Ellefson; William K Reagen; Mark Strynar; Steven O'Connell; Craig M Butt; Scott A Mabury; Jeff Small; Derek C G Muir; Stefan D Leigh; Michele M Schantz Journal: Anal Bioanal Chem Date: 2009-10-28 Impact factor: 4.142
Authors: Stephanie J Frisbee; A Paul Brooks; Arthur Maher; Patsy Flensborg; Susan Arnold; Tony Fletcher; Kyle Steenland; Anoop Shankar; Sarah S Knox; Cecil Pollard; Joel A Halverson; Verónica M Vieira; Chuanfang Jin; Kevin M Leyden; Alan M Ducatman Journal: Environ Health Perspect Date: 2009-07-13 Impact factor: 9.031
Authors: Matthew O Gribble; Scott M Bartell; Kurunthachalam Kannan; Qian Wu; Patricia A Fair; Diane L Kamen Journal: Environ Res Date: 2015-03-26 Impact factor: 6.498
Authors: Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken Journal: Environ Int Date: 2019-05-28 Impact factor: 9.621
Authors: J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster Journal: Toxicol Appl Pharmacol Date: 2020-08-19 Impact factor: 4.219
Authors: Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton Journal: Toxicology Date: 2017-05-27 Impact factor: 4.221
Authors: Claire Looker; Michael I Luster; Antonia M Calafat; Victor J Johnson; Gary R Burleson; Florence G Burleson; Tony Fletcher Journal: Toxicol Sci Date: 2013-11-27 Impact factor: 4.849
Authors: Ana M Mora; Abby F Fleisch; Sheryl L Rifas-Shiman; Jennifer A Woo Baidal; Larissa Pardo; Thomas F Webster; Antonia M Calafat; Xiaoyun Ye; Emily Oken; Sharon K Sagiv Journal: Environ Int Date: 2017-11-20 Impact factor: 9.621
Authors: Deborah J Watkins; Gregory A Wellenius; Rondi A Butler; Scott M Bartell; Tony Fletcher; Karl T Kelsey Journal: Environ Int Date: 2013-11-18 Impact factor: 9.621
Authors: Xia Wen; Angela A Baker; Curtis D Klaassen; J Christopher Corton; Jason R Richardson; Lauren M Aleksunes Journal: Toxicology Date: 2019-01-24 Impact factor: 4.221